This event will feature Marc Lipsitch and be hosted by the Global Health Network. Learn more about the seminar here. Register here. The unprecedented speed and scale of global rollouts of COVID-19 vaccines is playing a critical role in effectively responding to the pandemic. Decisions about global vaccine rollout have been made rapidly, informed by best available clinical research findings. What ethical responsibilities arise to monitor the safety and effectiveness…

Continue reading "A Grand Experiment: Ethical Responsibilities in the Global Rollout of COVID-19 Vaccines"

This event will feature Marc Lipsitch and be hosted by Boston City Council's Committee on Government Operations. Learn more about the hearing here. Read the docket here. Watch the event here. This hearing will address Docket #0261: Ordinance requiring equitable COVID-19 vaccine distribution in the City of Boston. In addition to Dr. Lipsitch, witnesses include Dr. Cassandra Pierre of Boston Medical Center, Stan McLaren of Harvard Street Neighborhood Health Center,…

Continue reading "Equitable COVID-19 Vaccine Distribution in the City of Boston"

This event will feature Marc Lipsitch and be hosted by the Korean Academy of Science. Option to register here. Stream the event here. View the symposium agenda here. In the era of the COVID-19 pandemic, predictive research on the number of infections and deaths using statistics is actively being carried out. In particular, we are extensively researching in the fields of big data and AI analysis technology that go beyond existing mathematical,…

Continue reading "Accounting for Uncertainties in Prediction When Making Vaccine Policy"

Presented by Dr. Koen Pouwels, Senior Health Economist at Oxford University's Health Economics Research Centre. Register for the event here. Dr Koen Pouwels is a health economist at the University of Oxford. His current work focuses on SARS-CoV-2 and antimicrobial resistance modelling, spatiotemporal modelling to predict local antimicrobial resistance and SARS-CoV-2 infection prevalences based on non-random survey data, design of randomised trials to determine optimal duration of antibiotic therapy, economic…

Continue reading "Improving our use of existing antimicrobial resistance data and generating better data on optimal antibiotic duration by improving trial design in veterinary and human medicine (ID Epi Seminar Series)"

This event will feature Michael Mina and be hosted by Longwood Healthcare Leaders. A fee is required to attend. Learn more about the conference here. Learn more about the panel here. Register here. The Longwood Healthcare Leaders meeting, April 5-6, 2021, is centered on MIT’s Koch Institute via webconference with leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors, co-hosted by Nobel laureate and Biogen/Alnylam co-founder Phil…

Continue reading "Progress Towards Sustainable Vaccines for COVID-19"

This event will feature Marc Lipsitch and be hosted by Stanford University. Learn more about the event here. Register here. The concept of herd immunity has been applied for decades in epidemiology and public health, yet the COVID-19 pandemic has prompted new debate about the role of herd immunity in the pandemic response and confusion about what herd immunity entails. People in public arenas have seized on scientific uncertainty in…

Continue reading "The Science of Herd Immunity"

Presented by Mr. Muhammed Semakula, Senior Statistician and Health Scientific Innovation Analyst in the Rwanda Biomedical Center's Research Innovation and Data Science Division. Register for the event here. Muhammed Semakula, BSc, MSc is a Statistician with a strong knowledge in statistics methods and data analysis. During COVID-19 pandemic, Muhammed was assigned by GoR to lead COVID- 19 data science and IT solutions response for Rwanda Joint Task Force COVID-19. He…

Continue reading "How Rwanda Managed to Control COVID-19? (ID Epi Seminar Series)"

This event will feature Bill Hanage and be hosted by the General Court of the Commonwealth of Massachusetts. Learn more and watch here. "Massachusetts lawmakers charged with overseeing the state’s response to the coronavirus emergency will switch gears next week to learn about COVID-19 variants infiltrating the state, according to an agenda released this week. 'We really want to understand the variants that we’re seeing circulating in Massachusetts — which ones…

Continue reading "Hearing on COVID-19 Variants"

Presented by Dr. Dale Barnhart, Global Health Equity Research Fellow at Harvard Medical School in affiliation with Partners In Health. Register for the event here. Dale Barnhart's research focuses on the application of epidemiological methods to implementation science and program evaluation. She completed her doctorate in epidemiology at the Harvard T.H. Chan School of Public Health in 2019. As a research fellow with Harvard Medical School and Partners In Health, she…

Continue reading "Identifying vulnerabilities and supporting patients during COVID-19: cohort studies in 7 LMICs (ID Epi Seminar Series)"

This event will feature Michael Mina and be hosted by Integrity Continuing Education. Learn more about the event here. Register here. This program is intended for infectious disease experts, immunologists, geriatricians, primary care physicians, nurse practitioners, physician’s assistants, nurses, and other members of the healthcare team involved in, or interested in, education regarding COVID-19 vaccines. Although much remains unknown about coronavirus disease 2019 (COVID-19), knowledge is expanding every hour, and…

Continue reading "Keeping Abreast of the Development of Vaccines to Prevent COVID-19: What Clinicians Need to Know"

This event will feature Michael Mina and be hosted by Harvard University. Learn more about the seminar series here. Register here. Advances in biological and computational sciences have enabled massive leaps in basic research and medicine over the recent decades. Relative to these medical advances, advances in public health and particularly infectious diseases have been modest. The SARS-CoV2 pandemic has shown us the consequences of investing so fully in medicine without…

Continue reading "Advances in virology, immunology, and computation to monitor and control outbreaks"

This event will feature Michael Mina and be hosted jointly by the Ragon Institute, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, and Harvard Medical School. It is part of a larger, free course called "Understanding COVID-19: Evolution of an Epidemic." Learn more about the course here. Register for the course here.   Understanding COVID-19 is a 2-day course (April 20th and 21st) intended to provide interested high…

Continue reading "Epidemiology, Testing, and Public Health Policy for COVID-19"

This event will feature Michael Mina and be hosted by the Harvard T.H. Chan School of Public Health. Learn more about and join the event here. What are the implications that five COVID-19 variants that appear to spread faster than other variants are now circulating in the United States? How might continuing vaccination rollouts and the availability of over-the-counter rapid antigen at-home tests factor into controlling further spread? And what is…

Continue reading "The Coronavirus Pandemic: The Latest on Variants and Rapid Testing"

Presented by Dr. Pia Abel-zur Wiesch, Associate Professor of Biology and Early Career Chair of Systems Pharmacology in The Pennsylvania State University's Department of Biology. Register for the event here. Dr. Abel zur Wiesch grew up in Freiburg, Germany where she attended latin school majoring in mathematics and chemistry. She went on to study biochemistry and molecular biology at the University of Kiel, Germany, Griffith University, Australia and University Basel,…

Continue reading "On the Interface Between Chemical Kinetics and
 Population Biology: How to Design Drug Dosing Strategies (ID Epi Seminar Series)"

This event will feature Michael Mina and be hosted by the Dana Farber Cancer Institute. Learn more about the event here. Join the event here. This event will be moderated by Alan Engelman, Ph.D., and Kai Wucherpfennig, M.D., Ph.D. Michael's fellow panelists will be Ralph S. Baric, Ph.D., Dan H. Barouch, M.D., Ph.D.    

This event will feature Marc Lipsitch and be hosted by the Alan Turing Institute’s JBC-Turing-RSS Laboratory. Learn more about the event here. Register here. In this seminar, Professor Lipsitch will discuss the challenges of understanding COVID-19 transmission, clinical course, and prevention. For transmission, he'll discuss the challenges of household and other secondary attack studies as described in a recent review, as well as some ways to address these challenges. For clinical course,…

Continue reading "Methodological challenges and approaches in COVID-19 epidemiology"

This event will feature Michael Mina and be hosted by the Harvard T.H. Chan School of Public Health. Learn more about the event here. Fourteen months into an unprecedented, worldwide pandemic, we now find ourselves on the precipice of hope. Thanks to the miracle of science and increases in production and distribution, the U.S. is now averaging more than 3 million vaccinations a day. Yet many hurdles remain. A race against…

Continue reading "A Look Back, A Path Forward: COVID-19"

Presented by Dr. Faith Osier, Professor of Immunology at Heidelberg University, Germany, and Executive Director of the IAVI Human Immunology Laboratory at Imperial College London. Register for the event here. Faith Osier trained as a paediatrician in Kenya, specialized in immunology in Liverpool, and obtained a PhD from the Open University in the UK. Her work in malaria vaccine development focuses on vaccine candidate discovery, the identification of correlates of protection…

Continue reading "Fc-dependent IgG parasite clearance as a guide for vaccine development against P. falciparum malaria (ID Epi Seminar Series)"

This event will feature Caroline Buckee and be hosted by CrisisReady. Learn more about the event here. Register here. Throughout the Covid-19 pandemic digital data on human mobility has played crucial roles in response efforts ranging from monitoring non-pharmaceutical interventions like physical distancing, evaluating different types of testing and seroprevalence strategies, and assisting with targeted re-opening efforts to maximize health and reduce economic harm. But persistent questions remain about the…

Continue reading "Ground Truth Matters: Travel Surveys, Covid-19, and the Limits of Human Mobility Data"